Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. Methotrexate (MTX) has been described to ...
A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary ...
QUEBEC, Feb. 19, 2026 /CNW/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating ...
After obtaining written informed consent, subjects (n=26; 18–35 years) underwent a Structured Clinical Interview for DSM-IV (SCID) (First et al, 2002) and were carefully screened for any DSM Axis I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results